SANOFI's gross profit margin for the third quarter of its fiscal year 2014 has increased when compared to the same period a year ago. Sales and net income have dropped, underperforming the average competitor within its industry.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q3 FY14||Q3 FY13|
|Net Sales ($mil)||9491.77||12381.87|
|Net Income ($mil)||1305.09||1725.36|
|Balance Sheet||Q3 FY14||Q3 FY13|
|Cash & Equiv. ($mil)||0.0||0.0|
|Total Assets ($mil)||0.0||0.0|
|Total Debt ($mil)||0.0||0.0|
|Profitability||Q3 FY14||Q3 FY13|
|Gross Profit Margin||61.62||58.22|
|Return on Assets||0.0||0.0|
|Return on Equity||0.0||0.0|
|Debt||Q3 FY14||Q3 FY13|
|Share Data||Q3 FY14||Q3 FY13|
|Shares outstanding (mil)||2624.22||2651.79|
|Div / share||0.0||0.0|
|Book value / share||0.0||0.0|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||3104948.0||1145516.0|
BUY. This stock's P/E ratio indicates a significant discount compared to an average of 32.82 for the Pharmaceuticals industry and a premium compared to the S&P 500 average of 18.81. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, SANOFI proves to trade at a discount to investment alternatives within the industry.
|SNY 22.50||Peers 32.82||SNY NA||Peers 19.86|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
SNY is trading at a significant discount to its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|SNY 13.85||Peers 18.50||SNY 0.34||Peers 0.62|
Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.
SNY is trading at a discount to its peers.
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
SNY trades at a significant discount to its peers.
|SNY NA||Peers 6.82||SNY 25.00||Peers -14.18|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
Ratio not available.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
SNY is expected to have an earnings growth rate that significantly exceeds its peers.
|SNY 2.69||Peers 6.31||SNY -4.30||Peers 11.02|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
SNY is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
SNY significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV